Monopar Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Monopar Therapeutics Inc. (MNPR) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $56.74 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $56.74K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $85.12K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $13.29K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $26.58K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $56.74K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $85.12K 10-Q · filed 2026-05-14 |
| 2025-09-30 | $13.29K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $26.58K 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |